Managing HIV Drug Resistance

Is There a Future for HIV-Infected Patients in "Deep Salvage"?

    144-Week Efficacy of Raltegravir in Treatment-Experienced Patients
    Survey Results: Physicians Reporting Number of Patients With GSS = 0 or 1 in Their Practice
    Geographical Distribution
    If you have not applied for early access of investigational agents for your MDR patients with limited to no options in the past, what were the main barriers to do so? (Check all that apply.)
    HIV Drug Pipeline -- 2011
    Nelson Vergel, B.S.Ch.E., M.B.A.

    Nelson Vergel, B.S.Ch.E., M.B.A.